Ensign Peak Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,989
Closed -$32K 1718
2025
Q4
$32K Sell
7,989
-15,100
-65% -$83.9K ﹤0.01% 1680
2025
Q3
$195K Sell
23,089
-13,000
-36% -$126K ﹤0.01% 1648
2025
Q2
$406K Hold
36,089
﹤0.01% 1605
2025
Q1
$342K Hold
36,089
﹤0.01% 1627
2024
Q4
$406K Hold
36,089
﹤0.01% 1649
2024
Q3
$1.02M Hold
36,089
﹤0.01% 1310
2024
Q2
$690K Hold
36,089
﹤0.01% 1496
2024
Q1
$1.18M Sell
36,089
-1,821
-5% -$58.1K ﹤0.01% 1206
2023
Q4
$1.25M Sell
37,910
-142,659
-79% -$4.04M ﹤0.01% 1211
2023
Q3
$4.92M Buy
180,569
+149,959
+490% +$4.17M 0.01% 569
2023
Q2
$927K Hold
30,610
﹤0.01% 1325
2023
Q1
$993K Hold
30,610
﹤0.01% 1244
2022
Q4
$860K Buy
30,610
+4,350
+17% +$125K ﹤0.01% 1284
2022
Q3
$944K Sell
26,260
-4,030
-13% -$142K ﹤0.01% 1094
2022
Q2
$930K Hold
30,290
﹤0.01% 1144
2022
Q1
$978K Buy
30,290
+16,480
+119% +$431K ﹤0.01% 1218
2021
Q4
$382K Buy
+13,810
New +$396K ﹤0.01% 1723

Other funds holding EVH

Ensign Peak Advisors's EVH Position: Q1 2026 in Review

Ensign Peak Advisors sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 7,989 shares — an estimated $32K sold.

Ensign Peak Advisors first reported a position in EVH in Q4 2021 and held it in 17 quarters. The position peaked at $4.92M in Q3 2023. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Ensign Peak Advisors reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Ensign Peak Advisors sold 7,989 Evolent Health shares in Q1 2026, an estimated $32K.
  • Ensign Peak Advisors first reported a position in Evolent Health in Q4 2021 and held it in 17 quarters.
  • Ensign Peak Advisors's Evolent Health position peaked at $4.92M in Q3 2023.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.